A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model

Microb Pathog. 2023 Sep:182:106262. doi: 10.1016/j.micpath.2023.106262. Epub 2023 Jul 18.

Abstract

Purpose: Due to its high drug resistance, Acinetobacter baumannii is a priority for new therapeutic measures like vaccines. In this study, the protectivity of a combination cocktail of Omp34 and BauA as a vaccine against A. baumannii was studied in a murine sepsis model.

Methods: The antibody titers were raised to Omp34 and BauA in BALB/c mice and assessed by indirect ELISA. The immunized mice were challenged with A. baumannii ATCC 19606. The bacterial loads in the liver, spleen, and lungs were also determined.

Results: A significant increase in survival of the immunized mice was noted. In active immunity, the survival rates in mice receiving Omp34 and BauA alone or in combination were 100%. A significant decrease in the bacterial load was observed in the spleens, livers, and lungs of vaccinated mice. Anti-BauA and anti-Omp34 sera crossly detected Omp34 and BauA respectively. The decrease in bacterial load in body organs of mice vaccinated with a combination of the two proteins was significantly higher than those of the single proteins in both actively and passively immunized mice. In passive immunity, the survival rate of mice receiving specific sera raised to the combination of these proteins was 85.7%.

Conclusion: Higher protection by a combination of Omp34 and BauA than Omp34 or BauA could be attributed to targeting simultaneously both surface antigens indicating the synergistic effect of Omp34 and BauA as suitable vaccine candidates in the prevention or treatment of A. baumannii infections.

Keywords: Acinetobacter baumannii; BauA; Cocktail vaccine; Immunogenicity; Omp34.

MeSH terms

  • Acinetobacter baumannii*
  • Animals
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Immunity
  • Lung
  • Mice
  • Vaccines*

Substances

  • Bacterial Outer Membrane Proteins
  • Vaccines
  • Bacterial Vaccines